Global Practicing Guidelines Task Force: International Laboratory Survey

Question Title

2. Professional organization affiliations (select all that apply)

ABH

APHIA

ARSHI

ASHI

EFI

Other (please specify)

Question Title

3. Laboratory accreditation (select all that apply)

AABB

ASHI

CAP

EFI

ISO

National Regulatory Body

Other (please specify)

Question Title

4. Regulatory frameworks followed (select all that apply)

ASHI

CAP

CLIA

EFI

ISO 15189

National Standards

Other (please specify)

Question Title

5. Scope of laboratory testing (select all that apply)

SOT

HCT

Donor registry or OPO

Transfusion Service Support

Research + Clinical

Research only

Non-transplant purpose (e.g. disease associations and pharmacogenetics)

Question Title

6. Testing categories performed (select all that apply)

HLA typing

Antibody detection

Crossmatching

Chimerism

Non‑HLA antibody testing

Non-HLA typing- KIR

Non-HLA typing-MICA

Non-HLA typing-HPA

Non-HLA typing-HNA

HLA loss after HCT

Non-HLA typing-ABO

ABO antibody titer

Other (please specify)

Section 2. Priority Areas for Future Guidelines

Question Title

7. Please rate how helpful consensus guidelines would be in the following areas.
Select 'Critically Needed' for no more than three areas.

	No Need	Moderate Need	Critically Needed
Quality management (QC and QA) and regulatory compliance	Quality management (QC and QA) and regulatory compliance No Need	Quality management (QC and QA) and regulatory compliance Moderate Need	Quality management (QC and QA) and regulatory compliance Critically Needed
Facility & laboratory infrastructure	Facility & laboratory infrastructure No Need	Facility & laboratory infrastructure Moderate Need	Facility & laboratory infrastructure Critically Needed
Molecular HLA typing methodologies	Molecular HLA typing methodologies No Need	Molecular HLA typing methodologies Moderate Need	Molecular HLA typing methodologies Critically Needed
Antibody detection and identification	Antibody detection and identification No Need	Antibody detection and identification Moderate Need	Antibody detection and identification Critically Needed
Crossmatching and compatibility assessment	Crossmatching and compatibility assessment No Need	Crossmatching and compatibility assessment Moderate Need	Crossmatching and compatibility assessment Critically Needed
Chimerism testing	Chimerism testing No Need	Chimerism testing Moderate Need	Chimerism testing Critically Needed
Post‑transplant immune monitoring	Post‑transplant immune monitoring No Need	Post‑transplant immune monitoring Moderate Need	Post‑transplant immune monitoring Critically Needed
Bioinformatics and data interpretation	Bioinformatics and data interpretation No Need	Bioinformatics and data interpretation Moderate Need	Bioinformatics and data interpretation Critically Needed
Emerging technologies (AI, automation, novel assays)	Emerging technologies (AI, automation, novel assays) No Need	Emerging technologies (AI, automation, novel assays) Moderate Need	Emerging technologies (AI, automation, novel assays) Critically Needed

Other (please specify)

Section 3. Specific Topics Where Guidance Is Needed
Please rank each of the following sections from “most useful” to “least useful”

Question Title

8. Quality Management (including QC and QA) - move items up and down to rank them

Question Title

9. Facility & Laboratory Infrastructure - move items up and down to rank them

Question Title

10. Molecular HLA Typing - move items up and down to rank them

Question Title

11. Antibody Detection - move items up and down to rank them

Question Title

12. Crossmatching - move items up and down to rank them

Question Title

13. Chimerism - move items up and down to rank them

Question Title

14. Post‑Transplant Monitoring - move items up and down to rank them

Question Title

15. Emerging Areas - move items up and down to rank them

Section 4. Emerging Guideline Needs

Question Title

16. In your opinion, what is the single most complex or ambiguous area in histocompatibility testing where international consensus guidelines would improve laboratory practice?

Section 5. Preferred Format for Future Guidelines

Question Title

17. Preferred format for guidelines (select all that apply)

High‑level principles

Minimum requirements + best practices

Detailed SOP guidance

Decision trees

Case examples

Question Title

18. Preferred length of guidelines

Short consensus statements

Moderate practical guidance

Comprehensive technical documents

Global Practicing Guidelines Task Force: International Laboratory Survey

Question Title

* 1. Country (Required.)

Question Title

* 2. Professional organization affiliations (select all that apply)

Question Title

* 3. Laboratory accreditation (select all that apply)

Question Title

* 4. Regulatory frameworks followed (select all that apply)

Question Title

* 5. Scope of laboratory testing (select all that apply)

Question Title

* 6. Testing categories performed (select all that apply)

Question Title

* 7. Please rate how helpful consensus guidelines would be in the following areas.Select 'Critically Needed' for no more than three areas.

Question Title

* 8. Quality Management (including QC and QA) - move items up and down to rank them

Question Title

* 9. Facility & Laboratory Infrastructure - move items up and down to rank them

Question Title

* 10. Molecular HLA Typing - move items up and down to rank them

Question Title

* 11. Antibody Detection - move items up and down to rank them

Question Title

* 12. Crossmatching - move items up and down to rank them

Question Title

* 13. Chimerism - move items up and down to rank them

Question Title

* 14. Post‑Transplant Monitoring - move items up and down to rank them

Question Title

* 15. Emerging Areas - move items up and down to rank them

Question Title

* 16. In your opinion, what is the single most complex or ambiguous area in histocompatibility testing where international consensus guidelines would improve laboratory practice?

Question Title

* 17. Preferred format for guidelines (select all that apply)

Question Title

* 18. Preferred length of guidelines

Question Title

* 19. Any comments for the Task Force Organizers? Please include an email address if you require clarification and/or follow -up.

Question Title

* 20. Enter your Email address to be entered into the $50 gift card drawing:

1. Country (Required.)

2. Professional organization affiliations (select all that apply)

3. Laboratory accreditation (select all that apply)

4. Regulatory frameworks followed (select all that apply)

5. Scope of laboratory testing (select all that apply)

6. Testing categories performed (select all that apply)

7. Please rate how helpful consensus guidelines would be in the following areas.
Select 'Critically Needed' for no more than three areas.

8. Quality Management (including QC and QA) - move items up and down to rank them

9. Facility & Laboratory Infrastructure - move items up and down to rank them

10. Molecular HLA Typing - move items up and down to rank them

11. Antibody Detection - move items up and down to rank them

12. Crossmatching - move items up and down to rank them

13. Chimerism - move items up and down to rank them

14. Post‑Transplant Monitoring - move items up and down to rank them

15. Emerging Areas - move items up and down to rank them

16. In your opinion, what is the single most complex or ambiguous area in histocompatibility testing where international consensus guidelines would improve laboratory practice?

17. Preferred format for guidelines (select all that apply)

18. Preferred length of guidelines

19. Any comments for the Task Force Organizers?
Please include an email address if you require clarification and/or follow -up.

20. Enter your Email address to be entered into the $50 gift card drawing: